-
1
المساهمون: Meza Gaviria, Antonio, Guzman Molano, Luisa fernanda
المصدر: 1. Ahmed F, Parthasarathy R, Khalil. Chronic daily headaches. Ann Indian Acad Neurol. 2012 Aug;15:40-50.
3. Dodick DW, Mauskop A. Botulinum toxin type A for profilaxis chronic headache. Headache 2005, 45:315-324.
2. Midgette LA, Scher AI. The epidemiology of chronic daily headache. Curr Pain Headache Rep.2009;13: 59-63.
4. Dodick DW. Chronic daily headaches . New England Journal, 2006;354:158-65.
5. Shilpa P.S., Rashna K. Botulinum toxin: the mifdas touch. J Nat Sci Biol Med. 2014 Jan-Jun; 5(1): 8–14.
6. Ahmed F, Parthasarathy R, Khalil M. Chronic daily headaches. Ann Indian Acad Neurol .2012;15:40-50
7. Carod-Artal FJ, Irimia P, Ezpeleta D. chronic migraine: definition, epidemiology, risk factors and treatment. RevNeurol 2012; 54 (10): 629-637
8. Pradilla G, Muñoz Cerón F. Dolor de Cabeza: epidemiología e impacto. Acta Neurol Colomb 2013;29:3-10.
9. Sobrino F. Cefalea crónica diaria. Acta Neurol Colomb 2013;29:96-106
Ward T. Migraine Diagnosis and Pathophysiology, Continuum Lifelong Learning Neurol 2012;18:753–763
11. Volcy M. Pathophysiology of chronic migraine. Acta Neurol Colomb 2013;29:25-30.
12. Kaniecki RG. Tension type headache, Continuum Lifelong Learning Neurol 2012;823–834
13. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 suppl 1:9-160
14. Halker RB, Hastriter EV, Dodick DW. Chronic daily headache: an evidence-based and systematic approach to a challenging problem. Neurology. 2011;76(7 suppl 2): S37-S43
Yancey JR, Maj MC. Chronic Daily Headache: Diagnosis and Management. Am Fam Physician. 2014;89(8):642-648
16. Dodick DW. Clinical practice. Chronic daily headache [published correction appears in N Engl J Med. 2006;354(8):884]. N Engl J Med. 2006;354(2):158-165
17. Matharu MS, Goadsby PJ. Trigeminal autonomic cephalgias. J Neurol Neurosurg Psychiatry. 2002;72 suppl 2:ii19-ii26
18. Goadsby PJ, Boes C. Chronic daily headache. J Neurol Neurosurg Psychiatry. 2002;72 suppl 2:ii2-ii5
19. Jull G, Trott P, Potter H, et al. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine (Phila Pa 1976). 2002;27(17): 1835-1843
20. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;(1):CD001218
21. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev. 2009;(1):CD007587
22. Devineni T, Blanchard EB. A randomized controlled trial of an internet-based treatment for chronic headache. Behav Res Ther. 2005;43(3):277-292
23. Nash JM, Park ER, Walker BB, Gordon N, Nicholson RA. Cognitive-behavioral group treatment for disabling headache. Pain Med. 2004;5(2):178-186
24. Thorn BE, Pence LB, Ward LC, et al. A randomized clinical trial of targeted cognitive behavioral treatment to reduce catastrophizing in chronic headache sufferers. J Pain. 2007;8:938-949
25. Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2014 Oct;34:944
26. Couch JR. Amitriptyline Versus Placebo Study Group. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache. 2011;51:33-51
27. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005
28. Saper JR, Lake AE III, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache. 2002;42:470-482
29. Lake III AE. Chronic daily headache: new treatment strategies. Presented at the World Congress of Neurology (WCN), November 15–17, 2002
30. Spira PJ, Beran RG; Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily
31. Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia. 2008;28:585-597
32. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Dabatase Syst Rev. 2004
33. Holroyd KA, O’Donnell FJ, Stensland M, et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination. JAMA 2001;285:2208–15
34. Drucker P, Tepper S. Daily sumatriptan for detoxification from rebound. Headache 1998; 38:687–90.
35. Dodick, D.W., Turkel, C.C., DeGryse, R.E., Aurora, S.K., Silberstein, S.D., Lipton, R.B., Diener, H.C., Brin, M.F., PREEMPT Chronic Migraine Study Group, 2010. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010;50:921–936
36. Kerner, J., 1822. Das Fettgift oder die Fettsaure und ihre Wirkungen auf den thierischen Organismus, ein Beytrag zur Untersuchung des in verdorbenen Wursten giftig wirkenden Stoffes. Cotta, Stuttgart; Tu¨ bingen
37. Erbguth, F.J. From poison to remedy: the chequered history of botulinum toxin. J. Neural Transm. 2008; 115: 559–565
38. Barnes, M. Botulinum toxin-mechanisms of action and clinical use in spasticity. J. Rehabil. Med. 2008;115: 56–59.
39. Thenganatt, M.A., Fahn, S. Botulinum toxin for the treatment of movement disorders. Curr. Neurol. Neurosci. Rep. 2012; 12: 399–409
40. Ivica M, Zdravko L. Botulinum toxin A, brain and pain. Progress in Neurobiology. 2014; 119–120
41. Grumelli C., Corradini I., Matteoli M., Verderio C. Intrinsic calcium dynamics control botulinum toxin A susceptibility in distinct neuronal populations. Cell Calcium, 2010; 47, 419–424
42. Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012; 307:1736-1745
43. Straube A, Empl M, Ceballos-Baumann A, Tölle T, Stefenelli U, Pfaffenrath V. Pericranial injection of botulinum toxin type A (Dysport) fortension type headache-a multicentre,double-blind, randomized, placebo-controlled study. Eur J Neurol-2008; 15: 205-13
44. Erdemoglu AK. The long-term efficacy and safety of botulinum toxin in refractory chronic tension type headache. J Headache Pain .2007; 8: 294-300
45. Hamdy SM. Botulinum toxin: could it be an effective treatment for chronic tension type headache. J Headache Pain .2009; 10: 27-34
46. Harden RN. Botulinum toxin a in the treatment of chronic tension type headache with cervical myofascial trigger points: a
47. Karadaay O. Botulinum neuro-toxin type-A in the treatment of chronic tension type headache associated with pericranial tenderness].-Agri-01-JAN-2012; 24(1): 9-14
48. Blumenfeld AM1, Schim JD, Chippendale TJ. Botulinum toxin type A and divalproex sodiumfor proplylatic treatment of episodic or chronic migraine. Headache 2008; 48: 210-220
49. Mathew NT, Frahan JS.A double blind coparision of BOTOX and topiramato. Headache 2009; 49: 1466-1478
50. Jakubowski M et al. Exploding vs inplonding headache in migraine prophylaxis with botulinumtoxin A. Pain 2006; 105:286-295مصطلحات موضوعية: MIGRAÑA, cefalea cronica diaria, toxina bolulinica, Botulinum Toxin, CEFALALGIA, TOXINAS BACTERIANAS, Chronic daily headache, TOXINAS BOTULINICAS
وصف الملف: pdf; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______2802::4992858c075a0a009921ed5ebe9ab926Test
https://hdl.handle.net/10654/7274Test -
2رسالة جامعية
المساهمون: Meza Gaviria, Antonio, Guzman Molano, Luisa fernanda
المصدر: 1. Ahmed F, Parthasarathy R, Khalil. Chronic daily headaches. Ann Indian Acad Neurol. 2012 Aug;15:40-50. ; 3. Dodick DW, Mauskop A. Botulinum toxin type A for profilaxis chronic headache. Headache 2005, 45:315-324. ; 2. Midgette LA, Scher AI. The epidemiology of chronic daily headache. Curr Pain Headache Rep.2009;13: 59-63. ; 4. Dodick DW. Chronic daily headaches . New England Journal, 2006;354:158-65. ; 5. Shilpa P.S., Rashna K. Botulinum toxin: the mifdas touch. J Nat Sci Biol Med. 2014 Jan-Jun; 5(1): 8–14. ; 6. Ahmed F, Parthasarathy R, Khalil M. Chronic daily headaches. Ann Indian Acad Neurol .2012;15:40-50 ; 7. ....
مصطلحات موضوعية: cefalea cronica diaria, toxina bolulinica, TOXINAS BOTULINICAS, TOXINAS BACTERIANAS, CEFALALGIA, MIGRAÑA, Chronic daily headache, Botulinum Toxin
جغرافية الموضوع: Medicina
وصف الملف: pdf; application/pdf
العلاقة: http://hdl.handle.net/10654/7274Test
الإتاحة: http://hdl.handle.net/10654/7274Test
